SCHEMBL9060291

SCHEMBL9060291

FC(Cl)C(F)(F)COCC(F)(F)C(F)Cl

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8736747 0.79 MEN1 (0.33) MEN1KMT2A
SCHEMBL6810507 0.76
SCHEMBL648441 0.75 MAPT (0.39) MEN1KMT2A
SCHEMBL1990358 0.75
SCHEMBL11501523 0.72
SCHEMBL497719 0.71 MEN1 (0.32) MEN1KMT2A
SCHEMBL30153329 0.71
SCHEMBL8160979 0.71
SCHEMBL1990697 0.69
SCHEMBL11897944 0.69 MAPT (0.36) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0546669-B1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR CO (GB) 1996-04-17 EP claimed
US-5385751-A Atmospheric pressure CVD process for preparing fluorine-doped tungsten oxide films FORD MOTOR COMPANY (US) 1995-01-31 US claimed
US-5286520-A Reacting tungsten hexafluoride, an oxygen containing compound and a fluorine containing compound FORD MOTOR COMPANY (US) 1994-02-15 US claimed
EP-0546669-A1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR COMPANY LIMITED (GB) 1993-06-16 EP claimed
US-4601917-A CHEMICAL VAPOR DEPOSITION M&T CHEMICALS INC. (US) 1986-07-22 US claimed
US-12479785-B2 Preparation of halogenated alkoxyethane COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2025-11-25 US disclosed
US-20240317662-A1 PRODUCTION OF HALOGENATED ALKOXYETHANE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-09-26 US disclosed
US-20240286986-A1 PURIFICATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-08-29 US disclosed
EP-4355719-A1 PRODUCTION OF HALOGENATED ALKOXYETHANE Commonwealth Scientific and Industrial Research Organisation (AU) 2024-04-24 EP disclosed
EP-4355718-A1 PURIFICATION PROCESS Commonwealth Scientific and Industrial Research Organisation (AU) 2024-04-24 EP disclosed
EP-4355720-A1 SYNTHESIS OF HALOGENATED ALKOXYETHANE Commonwealth Scientific and Industrial Research Organisation (AU) 2024-04-24 EP disclosed
US-20230053833-A1 PREPARATION OF HALOGENATED ALKOXYETHANE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2023-02-23 US disclosed
CN-115103827-A Preparation of haloalkoxyethanes 联邦科学和工业研究组织 2022-09-23 CN disclosed
WO-2021119717-A1 PREPARATION OF HALOGENATED ALKOXYETHANE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2021-06-24 WO disclosed
WO-2021119716-A1 PREPARATION OF HALOGENATED ALKOXYETHANE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2021-06-24 WO disclosed
EP-0546669-B1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR CO (GB) 1996-04-17 EP disclosed
US-5385751-A Atmospheric pressure CVD process for preparing fluorine-doped tungsten oxide films FORD MOTOR COMPANY (US) 1995-01-31 US disclosed
US-5286520-A Reacting tungsten hexafluoride, an oxygen containing compound and a fluorine containing compound FORD MOTOR COMPANY (US) 1994-02-15 US disclosed
EP-0546669-A1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR COMPANY LIMITED (GB) 1993-06-16 EP disclosed
US-4169790-A Solid surface texture suitable for a stationary phase for chromatography SOUTH AFRICAN INVENTIONS DEVELOPMENT CORPORATION (ZA) 1979-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479785-B2 Preparation of halogenated alkoxyethane CYP4F2, CYP2F1, CYFIP2 MEN1 3979/4885KMT2A 3892/4885
US-20240286986-A1 PURIFICATION PROCESS CFH, XDH, DCXR MEN1 3626/4885KMT2A 3270/4885
US-20230053833-A1 PREPARATION OF HALOGENATED ALKOXYETHANE CYP4F2, CYP2F1, CYP4F3 MEN1 4575/4885KMT2A 3705/4885
US-20240317662-A1 PRODUCTION OF HALOGENATED ALKOXYETHANE CYFIP2, CYP4F2, CFH MEN1 3132/4885KMT2A 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.